Attached files
file | filename |
---|---|
10-Q - Synthetic Biologics, Inc. | v193596_10q.htm |
EX-31.2 - Synthetic Biologics, Inc. | v193596_ex31-2.htm |
EX-31.1 - Synthetic Biologics, Inc. | v193596_ex31-1.htm |
EXHIBIT
32.1
CERTIFICATION PRINCIPAL
EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PURSUANT
TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley
Act of 2002, the undersigned officer of Adeona Pharmaceuticals, Inc. (the
“Registrant”) hereby certifies, to such officer’s knowledge,
that:
(1)
|
the
accompanying Quarterly Report on Form 10-Q of the Registrant for the
quarter ended June 30, 2010 (the “Report”) fully complies with the
requirements of Section 13(a) or Section 15(d), as applicable, of the
Securities Exchange Act of 1934, as amended; and
|
(2)
|
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Registrant.
|
Date: August 16, 2010 | |||
By:
|
/s/ James S. Kuo, M.D., M.B.A. | ||
Name:
James S. Kuo, M.D., M.B.A.
Title:
President and Chief Executive Officer
(Principal
Executive Officer and Principal Financial Officer)
|